• Collaborating to improve access and equity of care for sickle cell sufferers

    Harriet Smith is the Health Innovation Network's MTFM National Lead for Spectra Optia. In this blog, she outlines the collaborative efforts to improve the support available to people with sickle cell disease, and tackle long standing inequalities. Sickle cell disease (SCD) is a serious and lifelong health condition. People with SCD produce unusually shaped red [...]

  • Until tackling health inequalities becomes business as usual, innovation is our best chance of equity

    Dr Stuart Monk, National Programme Director for the Accelerated Access Collaborative (AAC) Programmes at the Health Innovation Network, talks about the pivotal role of innovation tackling healthcare inequalities in the NHS. At the Royal Society of Medicine’s Tackling Inequalities conference it was clear from the passion in the room that great progress has been made [...]

  • Sickle cell patients to benefit from £1.5M technology investment

    Hundreds of children, young people, and adults across England suffering from sickle cell disease will soon benefit from better care closer to where they live, following the announcement of a £1.5M investment in 25 red blood cell exchange devices. Funding for the Spectra Optia® Apheresis System devices has been distributed to 22 NHS trusts*, with [...]

  • Where health innovation is concerned, 15 approaches are better than one

    Dr Phil Jennings, Vice Chair of the Health Innovation Network and Chief Executive of Health Innovation North West Coast, discusses why the Network’s collective relicensing gives innovation a better chance of success. In any one day in England, 1.2 million people attend a GP appointment, over a quarter of a million people have an outpatient [...]

  • Connecting the NHS and global health tech innovators

    The Health Innovation Network is exhibiting at Arab Health (Monday 29 January to Thursday 1 February), which is the largest healthcare and medical trade show in the Middle East and North Africa. This year, we will be helping to showcase a number of UK-based innovators to the international healthcare audience. The innovators are: ImproveWell, which [...]

  • Minuteful Kidney – smartphone test that saves lives

    Summary Kidney care costs the NHS more than £1.5bn a year. Healthy.io's Minuteful Kidney home kidney albumin to creatinine ratio (ACR) test identifies more patients at-risk of Chronic Kidney Disease and associated cardiovascular disease. This provides an opportunity to identify patients most at risk, intervene, and improve patient care, which can help prevent the escalation [...]

  • Meet the innovator: Damian O’Boyle, Healthy.io

    Kidney care costs the NHS £1.5bn a year. Minuteful Kidney, from Healthy.io, is a home kidney albumin to creatinine ratio (ACR) test. It identifies more patients at-risk of chronic kidney disease (CKD) and associated cardiovascular disease (CVD), which is a leading cause of morbidity, disability and health inequalities. Damian O’Boyle, Director of Client Services at [...]

  • Innovator’s home-testing device trialled by NHS

    Technology developed by a Network-supported innovator is being sent by NHS England to 30,000 patients, who are considered most at risk for kidney disease. Minuteful Kidney, from Healthy.io, is a home kidney albumin to creatinine ratio (ACR) test. The trail is part of a £30 million technology and AI innovation fund. Analysis suggests the device [...]

  • Transforming sickle cell care: patient-centred solutions

    Sickle cell patients have helped identify key priorities to improve access to treatment across England. Published in a new report entitled ‘Appropriateness in access to automated red cell exchange: the patient perspective’, the five priority areas within the sickle cell treatment pathway that require attention and improvement are: Informed decision-making and talking to clinicians; Out [...]

  • Focus ADHD: a practical guide to adoption and spread

    Our new guide to innovation implementation, readiness and resourcing shares practical learning from the successful adoption and spread of our national Focus ADHD programme. Despite the impact of the pandemic on non-emergency services the three-year ADHD programme exceeded its targets and by June 2023 had benefited 65,000 young people. The new guide collates the critical [...]

  • Meet the Innovator: Paul McGinness, Lenus Health

    Major conditions like chronic cardiovascular and lung disease account for a disproportionate share of healthcare resources and are tied to inequalities. Lenus Health provide AI and digital tools to existing care pathways to improve healthcare delivery, reduce admissions and improve outcomes. We spoke to Paul McGinness, CEO and co-founder of Lenus Health to find out more. [...]

  • Meet the Innovator: James Hare, CEO of US2.ai

    Us2.ai is a fast-growing start-up, based in Singapore but now operating worldwide, which is dedicated to tackling CVD and heart disease through pioneering Artificial Intelligence (AI). Its mission is to improve patient outcomes and expand healthcare access by making echocardiograms, the most used tool for the detection of heart risk, available to all. We spoke [...]

  • Meet the Innovator: Dr George Harston, Brainomix

    Dr George Harston is Chief Medical and Innovation Officer at Brainomix. He is also a Consultant Physician in Stroke and General Medicine at Oxford University Hospitals NHS Foundation Trust. The company’s innovative AI-enabled decision support tools are helping clinicians to rapidly and accurately decide the type and severity of stroke, and the most appropriate treatment. It [...]

  • Supporting Sickle Cell Disease patients

    In this blog, Mary Aziz, Programme Development Lead at Health Innovation Manchester, explains how Spectra Optia, part of Accelerated Access Collaborative MedTech Funding Mandate policy, helps patients to have better care outcomes and quality of life. Sickle Cell Disease (SCD) is a genetic, life-long condition, detected during pregnancy or soon after birth through the national [...]

  • Health Innovation Manchester Impact Report 2022/23

    Health Innovation Manchester (HInM) has published its Impact Report for 2022-2023. The report details how HInM has delivered against all its key commissions from NHS England and the Office of Life Sciences through 2022/23. Key highlights in the report include: Strong delivery against all national AHSN requirements across its various commissions including delivery to the [...]

  • Improving tracheostomy care during Covid

    The NHS England National Patient Safety Team has published a case study about a successful programme to improve tracheostomy care during the Covid-19 pandemic. The AHSN Network worked with the NHS England National Patient Safety on the programme, which was launched in anticipation of an increase in patients requiring a temporary tracheostomy. This was due [...]

  • New resources for patients preparing for SMR

    The AHSN Network and its partners have developed a range of evidenced-based resources to support and help prepare people invited for a Structured Medication Review (SMR) with their GP, pharmacist or other healthcare professional. People may benefit from a Structured Medication Review if they are taking several medicines regularly or are taking medicines for long-term [...]

  • Innovate Awards 2023 – winners announced

    The second annual Innovate Awards were held yesterday (Thursday 21 September) at a ceremony in London, attended by NHS leaders, innovators, and partners. The Innovate Awards, delivered in partnership between the AHSN Network and NHS Confederation, celebrate innovation in health and care. Technology thought-leader and Countdown arithmetician, Dr Anne-Marie Imafidon MBE, hosted the ceremony. [...]

  • Future of Healthcare: the adoption of AI

    An article by Dr Rishi Das-Gupta, Chief Executive of Health Innovation Network South London, and Digital Transformation and Innovation Lead at the AHSN Network, has been published in a supplement available with The Guardian newspaper. The article is part of a Future of Healthcare campaign and outlines that while the adoption of AI in healthcare [...]

  • Study highlights success of PReCePT programme

    The success of PReCePT, a programme to increase the use of magnesium sulfate to prevent cerebral palsy in premature babies, has been highlighted in a new paper published in BJOG: An International Journal of Obstetrics and Gynaecology. The paper shares the findings of the Health Foundation funded PReCePT study, nested within the AHSN Network’s national [...]

  • Early Intervention Eating Disorders: final report

    The First episode Rapid Early intervention for Eating Disorders (FREED) programme has achieved several successes, according to the final learning report, which has now been published. These successes include increased access to early intervention for eating disorders, with 2,430 patients receiving FREED treatment, as well as an estimated cost savings to the NHS of [...]

  • Supporting better conversations about medicines

    The AHSN Network’s national Polypharmacy programme is helping healthcare professionals identify patients at potential risk of harm from ‘problematic pharmacy’. The programme is also supporting better conversations about medicines by promoting shared decision making, according to the findings of an interim evaluation of the programme’s first year. In England, the NHS primary care system dispenses [...]